AUAUniversity Podcast Series: Episode No. 30

Chemo-ablation of Upper-Tract Urothelial Carcinoma

Co-Host: Vitaly Margulis, MD

At the conclusion of these activities, participants will be able to:
1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks and benefits of treatment.
2. Facilitate discussions with patients and caregivers regarding of urothelial carcinoma treatment options.

This educational series is supported by independent educational grants from:
Amgen
Astellas
AstraZeneca
Bristol-Myers Squibb
Genomic Health
Merck
Pfizer, Inc.
Sanofi Genzyme
UroGen Pharma